共 104 条
- [1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin. 68 394-424
- [2] Ikoma N(2018)Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006–2014 using propensity score matching Gastric Cancer 21 1004-1013
- [3] Mizrak Kaya D(2018)Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma J. Surg. Oncol. 117 678-684
- [4] Shiozaki H(2016)Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases J. Surg. Oncol. 113 29-35
- [5] Chen C(2019)Efficacy and safety of immune checkpoint inhibitors in advanced gastric or gastroesophageal junction cancer: a systematic review and meta-analysis Oncoimmunology 8 e1581547-113
- [6] Taieb J(2018)Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: current status and future perspectives Cancer Treat. Rev. 66 104-464
- [7] Bartley AN(2017)HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology J. Clin. Oncol. 35 446-209
- [8] Wang R(2014)Comprehensive molecular characterization of gastric adenocarcinoma Nature 513 202-31
- [9] Tirosh I(2020)Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response Gut 69 18-196
- [10] Han X(2016)Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq Science 352 189-309